Your browser doesn't support javascript.
loading
Current Status and Prospects of Targeted Therapy for Osteosarcoma.
Hu, Zunguo; Wen, Shuang; Huo, Zijun; Wang, Qing; Zhao, Jiantao; Wang, Zihao; Chen, Yanchun; Zhang, Lingyun; Zhou, Fenghua; Guo, Zhangyu; Liu, Huancai; Zhou, Shuanhu.
Afiliación
  • Hu Z; Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.
  • Wen S; Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.
  • Huo Z; Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.
  • Wang Q; Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.
  • Zhao J; Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.
  • Wang Z; Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.
  • Chen Y; Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.
  • Zhang L; Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.
  • Zhou F; Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.
  • Guo Z; Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.
  • Liu H; Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.
  • Zhou S; Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Cells ; 11(21)2022 11 05.
Article en En | MEDLINE | ID: mdl-36359903
ABSTRACT
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS prognosis is poor, and improving the survival of OS patients remains a challenge. Current treatment methods such as surgical approaches, chemotherapeutic drugs, and immunotherapeutic drugs remain ineffective. As research progresses, targeted therapy is gradually becoming irreplaceable. In this review, several treatment modalities for osteosarcoma, such as surgery, chemotherapy, and immunotherapy, are briefly described, followed by a discussion of targeted therapy, the important targets, and new technologies for osteosarcoma treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: China